Published in Genes Dev on June 27, 2003
Regulation of B cell fate commitment and immunoglobulin heavy-chain gene rearrangements by Ikaros. Nat Immunol (2008) 2.40
Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling. Nat Rev Immunol (2009) 2.19
Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein. J Exp Med (2005) 2.00
Predicting cell-type-specific gene expression from regions of open chromatin. Genome Res (2012) 1.78
IRF8 regulates myeloid and B lymphoid lineage diversification. Immunol Res (2009) 1.68
The IRF family, revisited. Biochimie (2007) 1.64
IRF4: Immunity. Malignancy! Therapy? Clin Cancer Res (2009) 1.61
Epigenetic repression of the Igk locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2. Nat Immunol (2011) 1.59
IRF8 regulates B-cell lineage specification, commitment, and differentiation. Blood (2008) 1.53
Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4. Immunity (2013) 1.52
Ras orchestrates exit from the cell cycle and light-chain recombination during early B cell development. Nat Immunol (2009) 1.48
Identification of target genes and a unique cis element regulated by IRF-8 in developing macrophages. Blood (2005) 1.44
Ikaros and Aiolos inhibit pre-B-cell proliferation by directly suppressing c-Myc expression. Mol Cell Biol (2010) 1.42
Interferon regulatory factor 4 and 8 in B-cell development. Trends Immunol (2008) 1.41
Biallelic mutations in IRF8 impair human NK cell maturation and function. J Clin Invest (2016) 1.39
The IkappaB kinase complex and NF-kappaB act as master regulators of lipopolysaccharide-induced gene expression and control subordinate activation of AP-1. Mol Cell Biol (2004) 1.39
BLNK suppresses pre-B-cell leukemogenesis through inhibition of JAK3. Blood (2008) 1.23
IFN regulatory factor 8 restricts the size of the marginal zone and follicular B cell pools. J Immunol (2010) 1.22
Regulation of aicda expression and AID activity: relevance to somatic hypermutation and class switch DNA recombination. Crit Rev Immunol (2007) 1.19
E2A and IRF-4/Pip promote chromatin modification and transcription of the immunoglobulin kappa locus in pre-B cells. Mol Cell Biol (2006) 1.19
Critical role of IRF-5 in regulation of B-cell differentiation. Proc Natl Acad Sci U S A (2010) 1.19
A self-reinforcing regulatory network triggered by limiting IL-7 activates pre-BCR signaling and differentiation. Nat Immunol (2012) 1.18
Orchestrating B cell lymphopoiesis through interplay of IL-7 receptor and pre-B cell receptor signalling. Nat Rev Immunol (2013) 1.18
Transcription factor Ebf1 regulates differentiation stage-specific signaling, proliferation, and survival of B cells. Genes Dev (2012) 1.13
Interferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytes. J Virol (2008) 1.09
Transcription factor networks in B-cell differentiation link development to acute lymphoid leukemia. Blood (2015) 1.08
Interferon regulatory factor 8 integrates T-cell receptor and cytokine-signaling pathways and drives effector differentiation of CD8 T cells. Proc Natl Acad Sci U S A (2012) 1.02
Transcription-coupled eviction of histones H2A/H2B governs V(D)J recombination. EMBO J (2013) 1.01
IRF-4 functions as a tumor suppressor in early B-cell development. Blood (2008) 1.01
The transcription factors IRF8 and PU.1 negatively regulate plasma cell differentiation. J Exp Med (2014) 1.00
NF-kappaB activity marks cells engaged in receptor editing. J Exp Med (2009) 0.98
Conservation of transcription factor binding specificities across 600 million years of bilateria evolution. Elife (2015) 0.97
IKKα-mediated signaling circuitry regulates early B lymphopoiesis during hematopoiesis. Blood (2012) 0.97
IRF8 governs expression of genes involved in innate and adaptive immunity in human and mouse germinal center B cells. PLoS One (2011) 0.96
A role for interferon regulatory factor 4 in receptor editing. Mol Cell Biol (2008) 0.96
Ikaros is absolutely required for pre-B cell differentiation by attenuating IL-7 signals. J Exp Med (2013) 0.95
Shared and distinct functions of the transcription factors IRF4 and IRF8 in myeloid cell development. PLoS One (2011) 0.95
IRF4 controls the positioning of mature B cells in the lymphoid microenvironments by regulating NOTCH2 expression and activity. J Exp Med (2013) 0.95
IRF4 is a suppressor of c-Myc induced B cell leukemia. PLoS One (2011) 0.95
Differential expression of IRF8 in subsets of macrophages and dendritic cells and effects of IRF8 deficiency on splenic B cell and macrophage compartments. Immunol Res (2009) 0.93
Phospholipase Cgamma2 contributes to light-chain gene activation and receptor editing. Mol Cell Biol (2007) 0.92
Transcription factor Zfx controls BCR-induced proliferation and survival of B lymphocytes. Blood (2009) 0.92
IRF-4 suppresses BCR/ABL transformation of myeloid cells in a DNA binding-independent manner. J Biol Chem (2011) 0.92
Cooperation between deficiencies of IRF-4 and IRF-8 promotes both myeloid and lymphoid tumorigenesis. Blood (2010) 0.91
PDK1 regulates VDJ recombination, cell-cycle exit and survival during B-cell development. EMBO J (2013) 0.87
Lymphocyte development: integration of DNA damage response signaling. Adv Immunol (2012) 0.87
Sustained secretion of immunoglobulin by long-lived human tonsil plasma cells. Am J Pathol (2007) 0.87
The role of type 1 interferon in systemic sclerosis. Front Immunol (2013) 0.86
Pre-B cell receptor signaling induces immunoglobulin κ locus accessibility by functional redistribution of enhancer-mediated chromatin interactions. PLoS Biol (2014) 0.85
A new take on v(d)j recombination: transcription driven nuclear and chromatin reorganization in rag-mediated cleavage. Front Immunol (2013) 0.82
A role for IRF8 in B cell anergy. J Immunol (2013) 0.82
Prediction of Gene Activity in Early B Cell Development Based on an Integrative Multi-Omics Analysis. J Proteomics Bioinform (2014) 0.82
The Transcription Factor Bach2 Is Phosphorylated at Multiple Sites in Murine B Cells but a Single Site Prevents Its Nuclear Localization. J Biol Chem (2015) 0.81
Transcription factor IRF8 controls Th1-like regulatory T-cell function. Cell Mol Immunol (2015) 0.81
Tet2 and Tet3 cooperate with B-lineage transcription factors to regulate DNA modification and chromatin accessibility. Elife (2016) 0.80
Silencing and nuclear repositioning of the lambda5 gene locus at the pre-B cell stage requires Aiolos and OBF-1. PLoS One (2008) 0.80
Human pre-B cell receptor signal transduction: evidence for distinct roles of PI3kinase and MAP-kinase signalling pathways. Immun Inflamm Dis (2013) 0.80
IRF4 and IRF8: Governing the virtues of B Lymphocytes. Front Biol (Beijing) (2014) 0.79
Relevance of Interferon Regulatory Factor-8 Expression in Myeloid-Tumor Interactions. J Interferon Cytokine Res (2016) 0.79
PU.1 cooperates with IRF4 and IRF8 to suppress pre-B-cell leukemia. Leukemia (2016) 0.78
Interferon regulatory factor 4 (IRF-4) targets IRF-5 to regulate Epstein-Barr virus transformation. J Biol Chem (2011) 0.78
A novel mechanism for the autonomous termination of pre-B cell receptor expression via induction of lysosome-associated protein transmembrane 5. Mol Cell Biol (2012) 0.78
The BCL11A transcription factor directly activates RAG gene expression and V(D)J recombination. Mol Cell Biol (2013) 0.78
The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases. Br J Pharmacol (2015) 0.78
Balancing Proliferation with Igκ Recombination during B-lymphopoiesis. Front Immunol (2014) 0.77
Transcription factors regulating B cell fate in the germinal centre. Clin Exp Immunol (2015) 0.77
Promoter methylation and expression levels of selected hematopoietic genes in pediatric B-cell acute lymphoblastic leukemia. Blood Res (2015) 0.76
Validation and implementation of a method for microarray gene expression profiling of minor B-cell subpopulations in man. BMC Immunol (2014) 0.76
Control of Ig gene assembly: lessons from premature activation. EMBO J (2013) 0.75
Extramedullary plasmacytoma in the lung of a Doberman pinscher dog. Can Vet J (2014) 0.75
22q11.2 Deletion Syndrome due to a Translocation t(6;22) in a Patient Conceived via in vitro Fertilization. Mol Syndromol (2015) 0.75
DNA Damage: From Chronic Inflammation to Age-Related Deterioration. Front Genet (2016) 0.75
Differential correlation analysis of glioblastoma reveals immune ceRNA interactions predictive of patient survival. BMC Bioinformatics (2017) 0.75
mTOR-Bach2 cascade controls cell cycle and class switch recombination during B cell differentiation. Mol Cell Biol (2017) 0.75
Fra-2 regulates B cell development by enhancing IRF4 and Foxo1 transcription. J Exp Med (2017) 0.75
A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature (1991) 13.19
Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J Exp Med (1991) 10.87
IRF family of transcription factors as regulators of host defense. Annu Rev Immunol (2001) 8.18
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science (1994) 7.60
B cell development pathways. Annu Rev Immunol (2001) 6.94
Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature (1995) 4.84
Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. Science (1999) 4.77
Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell (1996) 4.74
Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science (1997) 4.23
Syk tyrosine kinase required for mouse viability and B-cell development. Nature (1995) 3.87
Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev (1995) 3.81
PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity. Mol Cell Biol (1992) 3.32
Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression. J Exp Med (2002) 3.16
A critical role of lambda 5 protein in B cell development. Cell (1992) 3.09
The Ig(kappa) enhancer influences the ratio of Ig(kappa) versus Ig(lambda) B lymphocytes. Immunity (1996) 2.39
The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansion. Nat Immunol (2002) 2.35
PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors. Immunity (2002) 2.10
A small molecule Abl kinase inhibitor induces differentiation of Abelson virus-transformed pre-B cell lines. Nat Immunol (2002) 2.07
Deletion of the Ig kappa light chain intronic enhancer/matrix attachment region impairs but does not abolish V kappa J kappa rearrangement. Immunity (1996) 1.96
Identification of very early lymphoid precursors in bone marrow and their regulation by estrogen. Nat Immunol (2001) 1.91
Regulation of an early developmental checkpoint in the B cell pathway by Ig beta. Science (1996) 1.88
Abnormal development and function of B lymphocytes in mice deficient for the signaling adaptor protein SLP-65. Immunity (1999) 1.84
Defective B cell receptor-mediated responses in mice lacking the Ets protein, Spi-B. EMBO J (1997) 1.73
Crystal structure of PU.1/IRF-4/DNA ternary complex. Mol Cell (2002) 1.64
Essential roles of the kappa light chain intronic enhancer and 3' enhancer in kappa rearrangement and demethylation. Nat Immunol (2002) 1.63
Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers. EMBO J (1999) 1.56
A novel enhancer in the immunoglobulin lambda locus is duplicated and functionally independent of NF kappa B. Genes Dev (1990) 1.43
In vivo occupancy of the kappa light chain enhancers in primary pro- and pre-B cells: a model for kappa locus activation. Immunity (1997) 1.38
Repertoire selection by pre-B-cell receptors and B-cell receptors, and genetic control of B-cell development from immature to mature B cells. Immunol Rev (2000) 1.37
The cell cycle and V(D)J recombination. Curr Top Microbiol Immunol (1996) 1.27
The transient expression of pre-B cell receptors governs B cell development. Semin Immunol (2002) 1.10
Differential surrogate light chain expression governs B-cell differentiation. Blood (2002) 1.03
Pre-B and pre-T-cell receptors: conservation of strategies in regulating early lymphocyte development. Immunol Rev (2000) 0.94
Insertion of phosphoglycerine kinase (PGK)-neo 5' of Jlambda1 dramatically enhances VJlambda1 rearrangement. J Exp Med (2001) 0.88
Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell (2010) 23.97
Subnuclear compartmentalization of immunoglobulin loci during lymphocyte development. Science (2002) 5.47
Multilineage transcriptional priming and determination of alternate hematopoietic cell fates. Cell (2006) 5.39
Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity (2006) 3.41
Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBPalpha ratio and granulocyte colony-stimulating factor. Nat Immunol (2003) 3.24
Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression. J Exp Med (2002) 3.16
IFN regulatory factor-4 and -8 govern dendritic cell subset development and their functional diversity. J Immunol (2005) 3.15
Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fates. Immunity (2002) 2.99
Regulation of immunoglobulin light-chain recombination by the transcription factor IRF-4 and the attenuation of interleukin-7 signaling. Immunity (2008) 2.72
Assembling a gene regulatory network for specification of the B cell fate. Dev Cell (2004) 2.46
Regulation of B cell fate commitment and immunoglobulin heavy-chain gene rearrangements by Ikaros. Nat Immunol (2008) 2.40
Contingent gene regulatory networks and B cell fate specification. Proc Natl Acad Sci U S A (2005) 2.36
A genomic regulatory element that directs assembly and function of immune-specific AP-1-IRF complexes. Science (2012) 2.30
Compensatory dendritic cell development mediated by BATF-IRF interactions. Nature (2012) 2.25
DNA sequence-dependent compartmentalization and silencing of chromatin at the nuclear lamina. Cell (2012) 2.20
Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5. Nat Immunol (2008) 2.19
PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors. Immunity (2002) 2.10
IL-17C regulates the innate immune function of epithelial cells in an autocrine manner. Nat Immunol (2011) 1.95
Early B cell factor cooperates with Runx1 and mediates epigenetic changes associated with mb-1 transcription. Nat Immunol (2004) 1.82
Initiation of allelic exclusion by stochastic interaction of Tcrb alleles with repressive nuclear compartments. Nat Immunol (2008) 1.78
Regulation of interleukin 7-dependent immunoglobulin heavy-chain variable gene rearrangements by transcription factor STAT5. Nat Immunol (2005) 1.76
A two-step, PU.1-dependent mechanism for developmentally regulated chromatin remodeling and transcription of the c-fms gene. Mol Cell Biol (2006) 1.67
CD86 is expressed on murine hematopoietic stem cells and denotes lymphopoietic potential. Blood (2012) 1.65
Crystal structure of PU.1/IRF-4/DNA ternary complex. Mol Cell (2002) 1.64
A recurrent network involving the transcription factors PU.1 and Gfi1 orchestrates innate and adaptive immune cell fates. Immunity (2009) 1.55
Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4. Immunity (2013) 1.52
Ras orchestrates exit from the cell cycle and light-chain recombination during early B cell development. Nat Immunol (2009) 1.48
Transcription factor c-Maf mediates the TGF-β-dependent suppression of IL-22 production in T(H)17 cells. Nat Immunol (2011) 1.41
Elevated and sustained expression of the transcription factors Egr1 and Egr2 controls NKT lineage differentiation in response to TCR signaling. Nat Immunol (2012) 1.35
Genetic networks that regulate B lymphopoiesis. Curr Opin Hematol (2005) 1.26
Specification of type 2 innate lymphocytes by the transcriptional determinant Gfi1. Nat Immunol (2013) 1.24
CPPsite: a curated database of cell penetrating peptides. Database (Oxford) (2012) 1.21
IRF-8 extinguishes neutrophil production and promotes dendritic cell lineage commitment in both myeloid and lymphoid mouse progenitors. Blood (2012) 1.19
Paracrine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins. J Clin Invest (2002) 1.19
A self-reinforcing regulatory network triggered by limiting IL-7 activates pre-BCR signaling and differentiation. Nat Immunol (2012) 1.18
B lymphopoiesis is active throughout human life, but there are developmental age-related changes. Blood (2002) 1.17
An incoherent regulatory network architecture that orchestrates B cell diversification in response to antigen signaling. Mol Syst Biol (2011) 1.17
Gene regulatory networks directing myeloid and lymphoid cell fates within the immune system. Semin Immunol (2008) 1.14
POU/TBP cooperativity: a mechanism for enhancer action from a distance. Mol Cell (2002) 1.14
PU.1-mediated upregulation of CSF1R is crucial for leukemia stem cell potential induced by MOZ-TIF2. Nat Med (2010) 1.12
NPACT: Naturally Occurring Plant-based Anti-cancer Compound-Activity-Target database. Nucleic Acids Res (2012) 1.11
Early lymphoid progenitors in mouse and man are highly sensitive to glucocorticoids. Int Immunol (2005) 1.10
Adiponectin, a fat cell product, influences the earliest lymphocyte precursors in bone marrow cultures by activation of the cyclooxygenase-prostaglandin pathway in stromal cells. J Immunol (2003) 1.10
CCDB: a curated database of genes involved in cervix cancer. Nucleic Acids Res (2010) 1.09
Altered chromosomal positioning, compaction, and gene expression with a lamin A/C gene mutation. PLoS One (2010) 1.08
TumorHoPe: a database of tumor homing peptides. PLoS One (2012) 1.07
Decitabine maintains hematopoietic precursor self-renewal by preventing repression of stem cell genes by a differentiation-inducing stimulus. Mol Cancer Ther (2010) 1.05
Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression. Br J Haematol (2009) 1.00
Remodeling and thrombosis following closure of coronary artery fistula with review of management: large distal coronary artery fistula--to close or not to close? Catheter Cardiovasc Interv (2013) 1.00
Ocular preservatives: associated risks and newer options. Cutan Ocul Toxicol (2009) 0.99
Hoxa9 regulates Flt3 in lymphohematopoietic progenitors. J Immunol (2010) 0.96
CancerDR: cancer drug resistance database. Sci Rep (2013) 0.96
Gene regulatory networks that orchestrate the development of B lymphocyte precursors. Adv Exp Med Biol (2007) 0.94
Shaping a helper T cell identity. Nat Immunol (2007) 0.92
Identification of mannose interacting residues using local composition. PLoS One (2011) 0.92
Cooperation between deficiencies of IRF-4 and IRF-8 promotes both myeloid and lymphoid tumorigenesis. Blood (2010) 0.91
Threshold levels of Flt3-ligand are required for the generation and survival of lymphoid progenitors and B-cell precursors. Eur J Immunol (2011) 0.91
Crystallization and characterization of PU.1/IRF-4/DNA ternary complex. J Struct Biol (2002) 0.86
Molecular pathways and mechanisms regulating the recombination of immunoglobulin genes during B-lymphocyte development. Adv Exp Med Biol (2009) 0.84
Lymphoid lineage cells in adult murine bone marrow diverge from those of other blood cells at an early, hormone-sensitive stage. Semin Immunol (2002) 0.84
Immunology: Short-term memory. Nature (2007) 0.84
EGFRIndb: epidermal growth factor receptor inhibitor database. Anticancer Agents Med Chem (2014) 0.84
Radiofrequency and cryoablation therapies for supraventricular arrhythmias in the young: five-year review of efficacies. Pacing Clin Electrophysiol (2012) 0.83
Congenital long QT 3 in the pediatric population. Am J Cardiol (2012) 0.83
Hoxa9 and Flt3 signaling synergistically regulate an early checkpoint in lymphopoiesis. J Immunol (2013) 0.83
Differential requirement for Hoxa9 in the development and differentiation of B, NK, and DC-lineage cells from Flt3+ multipotential progenitors. BMC Immunol (2013) 0.82
Development of effective ocular preparations of antifungal agents. J Ocul Pharmacol Ther (2008) 0.80
Methylphenidate-mediated reduction in prefrontal hemodynamic responses to working memory task: a functional near-infrared spectroscopy study. Hum Psychopharmacol (2012) 0.79
Development and evaluation of novel surfactant-based elastic vesicular system for ocular delivery of fluconazole. J Ocul Pharmacol Ther (2012) 0.78
The safety and efficacy of an accelerated iron sucrose dosing regimen in patients with chronic kidney disease. Kidney Int Suppl (2003) 0.78
Arrhythmias and sudden death among older children and young adults following tetralogy of Fallot repair in the current era: are previously reported risk factors still applicable? Congenit Heart Dis (2013) 0.78
Improved ocular absorption kinetics of timolol maleate loaded into a bioadhesive niosomal delivery system. Graefes Arch Clin Exp Ophthalmol (2010) 0.77
Immunology. Asymmetry and immune memory. Science (2007) 0.77
Optimizing paced ventricular function in patients with and without repaired congenital heart disease by contractility-guided lead implant. Pacing Clin Electrophysiol (2014) 0.76
The A-MYSM power of deubiquitinases. Immunity (2011) 0.75
Randomized Controlled Trial of Etodolac versus Combination of Etodolac and Eperisone in Patients of Knee Osteoarthritis. Pain Res Treat (2013) 0.75
Suitability of the internal mammary artery in an adult patient with coarctation of the aorta. Tex Heart Inst J (2005) 0.75
RAG-1 and Ly6D independently reflect progression in the B lymphoid lineage. PLoS One (2013) 0.75
Introductory perspective. Semin Immunol (2011) 0.75
Treating osteoarthritis in the elderly: should recent data on NSAIDs change our way of practice? South Med J (2007) 0.75
Genotype diversity in structure of amylopectin of waxy rice and its influence on gelatinization properties. Carbohydr Polym (2012) 0.75
Risk factors for atrioventricular tachycardia degenerating to atrial flutter/fibrillation in the young with Wolff-Parkinson-White. Pacing Clin Electrophysiol (2008) 0.75
Imidazo[1,2-a]pyridine Scaffold as Prospective Therapeutic Agents. Curr Top Med Chem (2017) 0.75